Mussini C - Search Results

1

Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved?

Jarrin I, Pantazis N, Dalmau J, Phillips AN, Olson A, Mussini C, Boufassa F, Costagliola D, Porter K, Blanco J, Del Amo J, Martinez-Picado J; for CASCADE Collaboration in EuroCoord. Jarrin I, et al. Among authors: mussini c. AIDS. 2015 Nov;29(17):2323-33. doi: 10.1097/QAD.0000000000000805. AIDS. 2015. PMID: 26544704 Free PMC article.

2

Lack of selective V beta deletion in CD4+ or CD8+ T lymphocytes and functional integrity of T-cell repertoire during acute HIV syndrome.

Cossarizza A, Ortolani C, Mussini C, Guaraldi G, Mongiardo N, Borghi V, Barbieri D, Bellesia E, Franceschini MG, De Rienzo B, et al. Cossarizza A, et al. Among authors: mussini c. AIDS. 1995 Jun;9(6):547-53. doi: 10.1097/00002030-199506000-00003. AIDS. 1995. PMID: 7662191

3

Mitochondria alterations and dramatic tendency to undergo apoptosis in peripheral blood lymphocytes during acute HIV syndrome.

Cossarizza A, Mussini C, Mongiardo N, Borghi V, Sabbatini A, De Rienzo B, Franceschi C. Cossarizza A, et al. Among authors: mussini c. AIDS. 1997 Jan;11(1):19-26. doi: 10.1097/00002030-199701000-00004. AIDS. 1997. PMID: 9110071

4

Deregulation of the CD95/CD95L system in lymphocytes from patients with primary acute HIV infection.

Cossarizza A, Stent G, Mussini C, Paganelli R, Borghi V, Nuzzo C, Pinti M, Pedrazzi J, Benatti F, Esposito R, Røsok B, Nagata S, Vella S, Franceschi C, De Rienzo B. Cossarizza A, et al. Among authors: mussini c. AIDS. 2000 Mar 10;14(4):345-55. doi: 10.1097/00002030-200003100-00007. AIDS. 2000. PMID: 10770536

5

Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/microl.

Mussini C, Bugarini R, Perno CF, Antinori A, Borghi V, Bertoli A, D'Arrigo R, Bedini A, Mongiardo N, Cossarizza A, Esposito R. Mussini C, et al. AIDS. 2002 Jul 26;16(11):1551-4. doi: 10.1097/00002030-200207260-00013. AIDS. 2002. PMID: 12131194 Clinical Trial.

6

Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy.

Mussini C, Pinti M, Borghi V, Nasi M, Amorico G, Monterastelli E, Moretti L, Troiano L, Esposito R, Cossarizza A. Mussini C, et al. AIDS. 2002 Aug 16;16(12):1609-16. doi: 10.1097/00002030-200208160-00006. AIDS. 2002. PMID: 12172082

7

MDR1 C3435T genetic polymorphism does not influence the response to antiretroviral therapy in drug-naive HIV-positive patients.

Nasi M, Borghi V, Pinti M, Bellodi C, Lugli E, Maffei S, Troiano L, Richeldi L, Mussini C, Esposito R, Cossarizza A. Nasi M, et al. Among authors: mussini c. AIDS. 2003 Jul 25;17(11):1696-8. doi: 10.1097/00002030-200307250-00016. AIDS. 2003. PMID: 12853754

8

Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. Study.

Murri R, Lepri AC, Phillips AN, Girardi E, Nasti G, Ferrara S, Mura MS, Mussini C, Petrelli E, Arlotti M, De Stefano C, Vigano P, Novati R, Cargnel A, Monforte AD; I.Co.N.A. Study Group. Murri R, et al. Among authors: mussini c. J Acquir Immune Defic Syndr. 2003 Oct 1;34(2):184-90. doi: 10.1097/00126334-200310010-00008. J Acquir Immune Defic Syndr. 2003. PMID: 14526207

9

Highly active antiretroviral therapy restores CD4+ Vbeta T-cell repertoire in patients with primary acute HIV infection but not in treatment-naive HIV+ patients with severe chronic infection.

Cossarizza A, Poccia F, Agrati C, D'Offizi G, Bugarini R, Pinti M, Borghi V, Mussini C, Esposito R, Ippolito G, Narciso P. Cossarizza A, et al. Among authors: mussini c. J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):213-22. doi: 10.1097/00126334-200403010-00001. J Acquir Immune Defic Syndr. 2004. PMID: 15076235 Clinical Trial.

10

Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes.

Ledergerber B, Lundgren JD, Walker AS, Sabin C, Justice A, Reiss P, Mussini C, Wit F, d'Arminio Monforte A, Weber R, Fusco G, Staszewski S, Law M, Hogg R, Lampe F, Gill MJ, Castelli F, Phillips AN; PLATO Collaboration. Ledergerber B, et al. Among authors: mussini c. Lancet. 2004 Jul 3-9;364(9428):51-62. doi: 10.1016/S0140-6736(04)16589-6. Lancet. 2004. PMID: 15234856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

747 results

Search Page